|
OGFRL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.116000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.561200E-01 |
| Normal-vs-Stage2 |
2.009400E-01 |
| Normal-vs-Stage3 |
5.757800E-01 |
| Normal-vs-Stage4 |
1.416180E-01 |
| Stage1-vs-Stage2 |
3.547900E-02 |
| Stage1-vs-Stage3 |
9.837800E-01 |
| Stage1-vs-Stage4 |
2.317000E-01 |
| Stage2-vs-Stage3 |
4.022200E-02 |
| Stage2-vs-Stage4 |
7.584700E-03 |
| Stage3-vs-Stage4 |
2.321200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.153000E-01 |
| Normal-vs-AfricanAmerican |
3.176000E-01 |
| Normal-vs-Asian |
6.379000E-01 |
| Caucasian-vs-AfricanAmerican |
6.360200E-01 |
| Caucasian-vs-Asian |
5.935900E-02 |
| AfricanAmerican-vs-Asian |
2.156200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.357400E-01 |
| Normal-vs-Female |
5.855000E-01 |
| Male-vs-Female |
8.155000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.089400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.970400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.989000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.873900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.074600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.213200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.925420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.507800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.581900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.362040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.334600E-01 |
| Classical-VS-Follicular |
5.3027027213659E-11 |
| Classical-VS-Other |
4.460200E-02 |
| Classical-VS-Normal |
9.690200E-02 |
| Tall-VS-Follicular |
1.64675999999586E-05 |
| Tall-VS-Other |
2.396000E-02 |
| Tall-VS-Normal |
1.221020E-01 |
| Follicular-VS-Other |
9.774200E-01 |
| Follicular-VS-Normal |
3.161500E-03 |
| Other-VS-Normal |
1.913610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.543600E-01 |
| Normal-vs-N1 |
1.720620E-01 |
| N0-vs-N1 |
1.632380E-02 |
|
|
